XML 139 R124.htm IDEA: XBRL DOCUMENT v3.20.1
FINANCIAL INFORMATION OF PARENT COMPANY - CONDENSED STATEMENTS OF CASH FLOWS (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2019
CNY (¥)
Dec. 31, 2018
CNY (¥)
Dec. 31, 2017
CNY (¥)
Cash flows from operating activities:        
Net loss $ (28,177,876) ¥ (196,168,740) ¥ (239,284,796) ¥ (112,092,907)
Adjustments for:        
Share-based compensation expenses 3,124,269 21,750,533 3,898,328 38,029,713
Fair value change on warrants liability (185,619) (1,292,244) (2,251,427) (12,615,466)
Amortization of discount and interest on convertible notes 4,762,302 33,154,191 98,308,205 76,990,826
Foreign exchange (gain) loss 786,291 5,474,002 20,331,430 (19,206,747)
Recovery of equity investment in excess of cost     0 (60,548,651)
Consulting fee paid by issuance of shares 5,040,605 35,091,686 4,172,800 13,454,692
Change in prepayments and other current assets (952,181) (6,628,897) (20,575,190) 3,169,076
Change in accounts payable 35,445 246,764 905,990 2,073,797
Change in accrued expenses and other current liabilities 1,708,802 11,896,337 (2,408,745) (7,943,127)
Net cash used in operating activities (7,781,799) (54,175,322) (101,200,526) (86,651,662)
Cash flows from investing activity:        
Settlement payment from investee     0 165,812,500
Cash flows from financing activities:        
Proceeds from other loans 5,010,342 34,881,000 0 19,881,900
Net cash provided by (used in) financing activities 5,878,192 40,922,800 (18,357,011) 44,073,433
Net change in cash and cash equivalents 841,261 5,856,692 (138,367,571) 103,745,944
Cash and cash equivalents, beginning of year 611,401 4,256,449 142,624,020 38,878,076
Cash and cash equivalents, end of year 1,452,662 10,113,141 4,256,449 142,624,020
Supplement disclosure of cash flow information:        
Interest paid     260,073 892,159
Income taxes paid     0 0
Parent Company        
Cash flows from operating activities:        
Net loss (25,538,677) (177,795,168) (217,092,926) (118,165,850)
Adjustments for:        
Share-based compensation expenses 3,117,763 21,705,240 3,645,751 37,727,861
Fair value change on warrants liability (185,619) (1,292,243) (2,251,427) (12,615,466)
Amortization of discount and interest on convertible notes 4,762,302 33,154,191 98,308,205 76,990,826
Foreign exchange (gain) loss 236,813 1,648,652 (1,963,364) (35,473,519)
Recovery of equity investment in excess of cost 0 0 0 (60,548,651)
Equity in loss of subsidiaries and VIEs 10,698,805 74,482,946 83,384,302 64,909,389
Consulting fee paid by issuance of shares 5,040,605 35,091,686 4,172,800 13,454,692
Change in prepayments and other current assets (272) (1,894) (2,971) 915,269
Change in amounts due from intercompany (4,030,631) (28,060,447) 30,882,203 (130,954,737)
Change in accrued expenses and other current liabilities 909,236 6,329,916 898,712 (2,092,500)
Net cash used in operating activities (4,989,675) (34,737,122) (18,715) (165,852,686)
Cash flows from investing activity:        
Settlement payment from investee 0 0 0 165,812,500
Cash flows from financing activities:        
Proceeds from other loans 5,010,341 34,881,000 0 0
Net cash provided by (used in) financing activities 5,010,341 34,881,000 0 0
Net change in cash and cash equivalents 20,666 143,878 (18,715) (40,186)
Cash and cash equivalents, beginning of year 3 18 18,733 58,919
Cash and cash equivalents, end of year 20,669 143,896 18 18,733
Supplement disclosure of cash flow information:        
Interest paid 0 0 0 0
Income taxes paid $ 0 ¥ 0 ¥ 0 ¥ 0